Warburg effect key to tumour growth, led by PKM2 enzyme.

One of the world's leading structural biologists, Helen Saibil, is bringing her knowledge -- and some spectacular images -- of molecular chaperones to the Lorne Protein conference.

Professor Emeritus Jack Pettigrew has argued for more than two decades that fruit bats are actually flying primates, distant relatives of monkeys, lemurs and us.

Did the evolution of C4 photosynthesis pathways in grasses helped kick-start modern human evolution as well?

Hepatitis C helicase unwinds DNA in a spring-loaded, three-step process.

Canadian researchers have developed a new technology to reveal the biochemical processes responsible for diseases such as cystic fibrosis.

Psiron (ASX:PSX) has announced that Stephen Jones will assume day-to-day control of the company, taking on the role of executive chairman. Julie Nutting will continue as the company's chief executive with responsibility for five clinical trial and manufacturing milestones for the company's CVA 21 virus by the end of the year.

Technology investment company ATP Innovations has taken equity in Sydney University spin-off Elastagen, investing AUD$250,000 to support commercialisation of the company's recombinant tissue-engineering protein tropoelastin.

There’s a distinct, rosy glow on the commercial horizon for unlisted Canberra vaccine developer Vaxine, with the company winning a AUD$770,000 AusIndustry R&D Start grant to advance its new-generation hepatitis B vaccine, and bringing in an equity partner to boost its cash reserves.

Sydney's Australian Technology Park biotech hub has grown to nine companies with two new businesses recently joining the BioFirst precinct.

Technology business commercialisation centre ATP Innovations has entered an agreement with Charles Sturt University and Wagga Wagga City Council to help put research on the track to market.